News
Videos
Conferences
Events
Resources
Subscribe

|Videos|March 22, 2017

Who Should Be Screened for CRC?

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Stage 3 colon cancer patients who tested MRD+ with Signatera after surgery saw a meaningful survival benefit from Celebrex and chemo: © stock.adobe.com.

This Test Helped Identify Treatment in Colorectal Cancer Surgery

December 19th 2025

The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases: © stock.adobe.com.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

BySpencer Feldman

December 16th 2025

Image of two people.

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

ByDr. Joshua K. Sabari

November 13th 2025

Image of hands.

I’m Still Here: My Fight Against Colorectal Cancer

ByChrista Messmer

October 28th 2025

Between paying for treatment, managing a reduced income, and understanding insurance, the financial side of cancer can feel overwhelming.

Financial Planning Support for People and Families Impacted by Cancer

ByTriage Cancer®

October 16th 2025

Trending on CURE

FDA Approves Six New Cancer Therapies in December 2025

‘Full House’ Star Dave Coulier on Taking Action in the Face of Cancer

Olvi-Vec Shows Early Activity in Small Cell and NSCLC Trials

FDA Application Submitted for Rusfertide Treatment in Polycythemia Vera

Cancer Risks of Veterans and First Responders Addressed at Summit